Tuhura Biosciences Inc (HURA)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
4.11 -0.09 (-2.14%) 04/15/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 4.00 -0.11 (-2.68%) 19:08 ET
for Tue, Apr 15th, 2025
Results
download Want to compare other data? Select FieldsSymbol | HURA | DSGN | ELDN | ||
Company | Tuhura Biosciences Inc | Design Therapeutics Inc | Eledon Pharmaceuticals Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 4.04 | 3.21 | 2.98 | ||
High | 4.20 | 3.38 | 3.21 | ||
Low | 3.96 | 3.21 | 2.91 | ||
Last | 4.11 | 3.32 | 3.01 | ||
Change | -0.09 | +0.07 | +0.03 | ||
% Change | -2.26% | +2.15% | +1.01% | ||
Volume | 166,900 | 186,100 | 145,700 | ||
20-Day Average Volume | 323,460 | 142,745 | 271,890 | ||
Previous Close | 4.20 | 3.25 | 2.98 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | No | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 3.66 | 3.78 | 3.19 | ||
20-Day Raw Stochastic | 89.79% | 28.92% | 38.10% | ||
20-Day Relative Strength | 57.41% | 39.95% | 38.93% | ||
Weighted Alpha | -60.16 | -25.06 | -7.91 | ||
Today's Opinion | 24% Sell | 88% Sell | 72% Sell | ||
Previous Opinion | 24% Sell | 88% Sell | 64% Sell | ||
Last Month's Opinion | 100% Sell | 32% Sell | 24% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | +9.47% since 04/08/25 | +12.54% since 04/08/25 | +11.07% since 04/08/25 | ||
Low | 3.45 on 04/09/25 | 2.60 on 04/11/25 | 2.63 on 04/09/25 | ||
High | 4.25 on 04/14/25 | 3.38 on 04/15/25 | 3.21 on 04/15/25 | ||
1-Month | |||||
%Chg | +80.04% since 03/14/25 | -29.44% since 03/14/25 | -17.53% since 03/14/25 | ||
Low | 2.11 on 03/17/25 | 2.60 on 04/11/25 | 2.61 on 04/07/25 | ||
High | 4.25 on 04/14/25 | 5.12 on 03/18/25 | 3.71 on 03/17/25 | ||
3-Month | |||||
%Chg | -14.12% since 01/15/25 | -23.85% since 01/15/25 | -25.68% since 01/15/25 | ||
Low | 1.80 on 03/10/25 | 2.60 on 04/11/25 | 2.61 on 04/07/25 | ||
High | 5.27 on 01/30/25 | 5.57 on 03/12/25 | 4.97 on 02/07/25 | ||
6-Month | |||||
%Chg | -48.33% since 10/15/24 | -38.40% since 10/15/24 | +2.03% since 10/15/24 | ||
Low | 1.80 on 03/10/25 | 2.60 on 04/11/25 | 2.61 on 04/07/25 | ||
High | 8.34 on 10/16/24 | 7.77 on 11/13/24 | 5.54 on 11/01/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 183,456 | 184,480 | 178,448 | ||
Shares Outstanding, K | 43,680 | 56,763 | 59,882 | ||
Annual Sales | 0 | 0 | 0 | ||
Annual Net Income | -21,680,000 | -49,590,000 | -36,180,000 | ||
Last Quarter Sales | 0 | 0 | 0 | ||
Last Quarter Net Income | -15,690,000 | -13,650,000 | -57,950,000 | ||
60-Month Beta | 0.80 | 1.82 | 0.66 | ||
Per-Share Information | |||||
Most Recent Earnings | -1.37 on 11/14/24 | -0.24 on 03/10/25 | -0.64 on 03/20/25 | ||
Latest Earnings Date | 05/13/25 | 05/14/25 | 05/08/25 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |